The effectiveness and safety of ledipasvir plus sofosbuvir in adolescents with chronic hepatitis C virus genotype 4 infection: a real-world experience.

H R El-KhayatEnas M KamalM H El-SayedM El-ShabrawiH AyoubA RizKM MaherR Y El SheemyY M FouadDina Attia

Published in: Alimentary pharmacology & therapeutics (2018)

A ledipasvir plus sofosbuvir regimen is well tolerated and effective, and can be used safely in treating adolescent patients with chronic hepatitis C genotype 4.

Keyphrases

hepatitis c virus
young adults
human immunodeficiency virus
mental health
physical activity
liver fibrosis